Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes

Blood

Volumn 102, Issue 5, 2003, Pages 1797-1805

  Zambello, Renato ^b   Falco, Michela ^b   Della Chiesa, Mariella ^b   Trentin, Livio ^b   Carollo, Davide ^b   Castriconi, Roberta ^b   Cannas, Giovanna ^b   Carlomagno, Simona ^b   Cabrelle, Anna ^b   Lamy, Thierry ^b   Agostini, Carlo ^b   Moretta, Alessandro ^a   Semenzato, Gianpietro ^b   Vitale, Massimo ^b  

^a Sezione di Istologia   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY; NATURAL CYTOTOXICITY RECEPTOR; NATURAL KILLER CELL RECEPTOR; NKP30 RECEPTOR; NKP46 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0042942800     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3898     Document Type: Article

References (55)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
2. Cooper M-A, Fehniger T-A, Caligiuri M-A. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633-640.
3. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol. 1996;14:619-648.
4. Lanier L-L. NK cell receptors. Annu Rev Immunol. 1998;16:359-393.
5. Long E-O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875-904.
6. Moretta A, Bottino C, Vitale M, et al. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197-223.
7. Andre P, Biassoni R, Colonna M, et al. New nomenclature for MHC receptors [letter]. Nat Immunol. 2001;2:661.
8. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186:1809-1815.
9. + NK clones. Int Immunol. 1999;11:29-35.
10. Braud V, Jones E-Y, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 1997;27:1164-1169.
11. Lee N, Llano M, Carretero M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A. 1998;95:5199-5204.
12. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
13. Moretta A, Sivori S, Vitale M, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 1995;182:875-884.
14. Bottino C, Sivori S, Vitale M, et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol. 1996;26:1816-1824.
15. Biassoni R, Cantoni C, Falco M, et al. The human leukocyte antigen (HLC)-C-specific "activatory" and "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 1996;183:645-650.
16. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 1997;158:5083-5086.
17. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips J-H, Lanier L-L. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 1995;25:2433-2437.
18. Cantoni C, Blassoni R, Pende D, et al. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol. 1998;28:327-338.
19. Sivori S, Vitale M, Morelli L, et al. p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J Exp Med. 1997;186:1129-1136.
20. Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505-1516.
21. Vitale M, Bottino C, Sivori S, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis. J Exp Med. 1998;187:2065-2072.
22. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727-729.
23. Pende D, Cantoni C, Rivera P, et al. Role of NKG2-D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;31:1076-1086.
24. Vitale M, Falco M, Castriconi R, et al. Identification of NKp80, a novel triggering molecule expressed by human natural killer cells. Eur J Immunol. 2001;31:233-242.
25. Kubin MZ, Parshley DL, Din W, et al. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counter structure for CD48. Eur J Immunol. 1999;29:3466-3477.
26. Sivori S, Parolini S, Falco M, et al. 2B4 functions as a co-receptor in human natural killer cell activation. Eur J Immunol. 2000;30:787-793.
27. Sivori S, Pende D, Bottino C, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells: correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 1999;29:1656-1666.
28. Ljunggren H-G, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
29. Pietra G, Semino C, Cagnoni F, et al. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically. J Med Virol. 2000;62:354-363.
30. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31:429-434.
31. Arase H, Mocarski E-S, Campbell A-E, Hill A-B, Lanier L-L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323-1326.
32. Smith HR, Heusel JW, Mehta IK, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A. 2002;99:8826-8831.
33. Scalzo A-A. Successful control of viruses by NK cells - a balance of opposing forces? Trends Microbiol. 2002;10:470-474.
34. Semenzato G, Pandolfi F, Chisesi T, et al. The lymphoproliferative disease of granular lymphocytes: a heterogeneous disorder ranging from indolent to aggressive conditions. Cancer. 1987;60:2971-2978.
35. Loughran T-P-J. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1-14.
36. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran T-P-J. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;86:256-260.
37. Zambello R, Semenzato G. Large granular lymphocytosis. Haematologica. 1998;83:936-942.
38. Lamy T, Loughran T-P-J. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230-240.
39. Zambello R, Loughran TPJ, Trentin L, et al. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia. 1995;9:1207-1211.
40. Zambello R, Trentin L, Ciccone E, et al. Phenotypic diversity of natural killer populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2381-2385.
41. Nash R, McSweeney P, Zambello R, Semenzato G, Loughran T-P-J. Clonal studies of CD3-lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2363-2368.
42. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the caucasioid population: Kir haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002;54:221-229.
43. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753-763.
44. Hsu KC, Liu X-R, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002;169:5118-5129.
45. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-caucasoid donors. Tissue Antigens. 2001;57:22-31.
46. Costello RJ, Sivori S, Marcenaro E, et al. Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia. Blood. 2002;99:3661-3667.
47. Vitale M, Sivori S, Pende D, et al. Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci U S A. 1996;93:1453-1457.
48. Pascal V, Brunet C, Pradel V, et al. Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation. Leukemia. 2002;16:2259-2266.
49. Hoffmann T, De Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol. 2000;110:525-536.
50. - (natural killer) lymphoproliferative disease of granular lymphocytes. Blood, 1997;90:1977-1981.
51. Pellenz M, Zambello R, Semenzato G, Loughran T-P-J. Detection of Epstein-Barr virus by PCR analyses in lymphoproliferative disease of granular lymphocytes. Leuk Lymphoma. 1996;23:371-374.
52. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
53. Shimodaira S, Ishida F, Kobayashi H, Mahbub B, Kawa-Ha K, Kitano K. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol. 1995;90:578-584.
54. Casado L-F, Granados E, Algara P, Navarro F, Martinez-Frejo M-C, Lopez-Botet M. High expression of the ILT2 (LIR- 1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients. Haematologica. 2001;86:457-463.
55. Zambello R, Facco M, Trentin L, et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood. 1997;89:201-211.